We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KFRC:NYSEKforce, Inc. Analysis

Data as of 2026-05-19 - not real-time

$40.65

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kforce Inc. (KFRC) is trading at $40.65, just above its 20‑day SMA of $40.17 and comfortably higher than the 50‑day ($33.04) and 200‑day ($31.27) averages, indicating a lingering bullish bias despite a bearish MACD signal (histogram –0.67) and a decreasing volume trend. The RSI sits at 58, suggesting neutral momentum, while the 30‑day volatility spikes above 115%, flagging heightened price swings. Fundamentals show flat year‑over‑year revenue (≈0.1% growth) but a solid ROE of 27% and a dividend yield of 3.89% with an 80% payout, supported by free cash flow that comfortably exceeds the dividend outlay. Valuation is mixed: the stock trades at a forward P/E of 13.86, well below the industry average of 29.5, yet the DCF‑derived fair value of $36.35 sits beneath the current price, implying only a modest 4% upside. The balance sheet is levered, with a debt‑to‑equity ratio of 91.5, though the low beta of 0.35 and a “Extreme Greed” sentiment index (89.6) temper market‑wide risk concerns. Recent earnings beat expectations, with GAAP EPS of $0.46 surpassing consensus, and management highlighted strategic AI investments to spur future growth. Overall, the stock presents a value‑oriented play with attractive income, but investors should monitor the high volatility, debt load, and the transition from flat to modest revenue growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Decreasing trading volume
  • Limited upside above current price

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive dividend yield and sustainable payout
  • Strong ROE and low beta
  • Forward P/E well below industry average

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Consistent dividend income
  • Low beta and defensive positioning
  • High debt‑to‑equity ratio limiting growth upside

Key Metrics & Analysis

Financial Health

Revenue Growth0.10%
Profit Margin2.60%
P/E Ratio20.6
ROE27.10%
ROA8.38%
Debt/Equity91.49
P/B Ratio5.6
Op. Cash Flow$57.3M
Free Cash Flow$57.9M
Industry P/E29.5

Technical Analysis

TrendBullish
RSI58.0
Support$31.10
Resistance$47.50
MA 20$40.17
MA 50$33.04
MA 200$31.27
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61

Valuation

Fair Value$36.35
Target Price$42.33
Upside/Downside4.14%
GradeFair
TypeValue
Dividend Yield3.89%

Risk Assessment

Beta0.35
Volatility115.83%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.